Oct 13 (Reuters) - The U.S. government has awarded diagnostic testing company Cue Health Inc $481 million to scale up the production of rapid COVID-19 molecular test, the Department of Health and ...
Home diagnostics company Cue Health announced its received FDA de novo authorization for its at-home COVID-19 test, dubbed the Cue COVID-19 Molecular Test. The Cue COVID-19 Molecular Test detects ...
SAN DIEGO, Oct. 6, 2022 /PRNewswire/ -- Cue Health Inc. (HLTH), a healthcare technology company, has partnered with actress Jamie-Lynn Sigler, the actress best known for her roles on The Sopranos and ...
The FDA granted emergency use authorization June 12 to healthcare tech company Cue Heath’s rapid COVID-19 test. The single-use molecular test identifies the RNA of the virus that causes COVID-19 from ...
As folks travel to see loved ones for the holiday season, there’s one thing no one wants to pack — an infectious disease. But whether you have the sniffles or just want to take precautions around ...
Hosted on MSN
What's the Deal With COVID Testing Now? Doctors Explain When to Test, How to Get Them and More
As we get into another winter holiday season, COVID is still part of our lives. And although it's hard to predict exactly what this year's cold, flu and coronavirus season will look like, experts want ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results